ArticleCancer immunology, immunotherapy : CII2013

AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial.

Sonia A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.